Abstract Sorcin, a 22-kDa calcium-binding protein, renders cancer cells resistant to chemotherapeutic agents, thus playing an important role in multidrug resistance. As there is a clear association between drug resistance and an aggressive phenotype, we asked whether sorcin affects also the motility, invasion, and stem cell characteristics of cancer cells. We have used both RNA interference (transient and stable expression of hairpins) and a lentiviral expression vector to experimentally modulate sorcin expression in a variety of cells. We demonstrate that sorcin depletion in MDA-MB-231 breast cancer cells reduces the pool of CD44
Introduction
Metastasis and chemoresistance play important roles in tumor recurrence and poor clinical outcome of cancer patients. A small subset of cancer cells, with self-renewal and differentiation features, the cancer stem cells (CSCs), are thought to be responsible for resistance to chemotherapy and cancer cell metastasis [1] . Differentiated mammary epithelial cells that have undergone epithelial-tomesenchymal transition (EMT, a key developmental program activated during cancer invasion and metastasis) have been reported to generate CD44 high CD24 low stem cell-like cells [2] . In addition, metastatic cells with CSC characteristics are found in a variety of cancers [3, 4] . More Yunhui Hu and Shuangjing Li contributed equally to this work. Senior corresponding authors, Ernesto Yagüe and Dongsheng Xiong contributed equally.
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recently, it has become evident that EMT not only leads to increased metastasis and a CSC phenotype, but also directly correlates with drug resistance [5] . In breast cancer, chemoresistance to 5-fluorouracil induces EMT via elevating expression of Snail [6] . Conversely, overexpression of EMT-related transcriptional factors increase multidrug resistance via up-regulation of ABC transporters, while attenuating EMT-inducing transcription factors sensitize breast cancer cells [7] . Such intimate association between EMT and chemoresistance has also been found in a variety of malignancies [8, 9] . These lines of evidence may provide us with novel therapeutic strategies to overcome tumor metastasis and recurrence via targeting the EMT, CSC and drug resistance junction.
Sorcin is a 22-kDa calcium-binding protein expressed in many tissues [10] where it regulates Ca 2? homeostasis and has been found to be up-regulated in gastric cancer [11] . Sorcin is an histological marker for malignant glioma [12] and forms part of the molecular signature of CD34
? haematopoietic stem and progenitor cells of patients with chronic myelogenous leukemia in chronic phase [13] . In addition, sorcin predicts poor outcome in acute myeloid leukemia [14] . Although the functional role of sorcin in cancer cells remains elusive, it is likely that its antiapoptotic function [15] leads to drug resistance in a variety of malignant cells [16, 17] .
Here, we report the role of sorcin in breast cancer metastasis via its effect on EMT and breast CSCs. Using stable silencing (shRNA), we demonstrate that depletion of sorcin attenuates CSCs increases E-cadherin expression and decreases vascular endothelial growth factor (VEGF) expression. This affects both the proportion of CSCs as defined by the CD44
? /CD24 -and ALDH1 high phenotype and their invasive properties in nude mice. These findings offer us the rationale to explore compounds or strategies to experimentally down-regulate sorcin expression in cancer.
Materials and methods

Cell culture
The breast cancer cell lines MDA-MB-231 and MCF-7, the lung cancer adenocarcinoma cell line A549, the lung fibrosarcoma cell line HT1080 were obtained from the American Type Culture Collection through the Cell Resource Centre of the Chinese Academy of Medical Sciences/Peking Union Medical College, Tianjin, China, and were authenticated by short tandem repeat profiling. Cells were cultured in DMEM (Invitrogen Life Technologies) with 10 % fetal calf serum and 2 mM L-glutamine (GIBCO). Cultures were maintained at 37°C in an air-5 % CO 2 incubator at constant humidity.
RNA interference
For stable knockdown of sorcin (shSorcin) and for control (shNC), annealed hairpins (Supplementary Table S1) were  cloned into pSilencer  TM 2.1-U6 hygro and transfected into  MDA-MB-231 cells using lipofectamin 2000 (Invitrogen) following the manufacture's standard protocol. Stable transfectants were selected using 800 lg/ml hygromycin (Sigma) and maintained with 50 lg/ml hygromycin. For transient transfections, 21-nucleotide siRNA duplex targeting human sorcin (Supplementary Table S1 ) and scrambled sequences (control siRNA) were designed using tools available at http://www.ambiom.com and synthesized by Genepharma. The siRNA duplexes were transfected into cells using lipofectamine 2000 according to the recommended protocol by the manufacturer.
Construction of lentivirus expression vectors and cell transfection
The *700-bp DNA fragment corresponding to the fulllength of sorcin coding sequence was generated by PCR from pcDNA3.1/sorcin [18] using the primers Sorcin-NheI and Sorcin-NotI (Supplementary Table S1 ) and cloned into the lentivirus expression vector pCDH1 (System Biosciences, SBI, USA). Lentiviral transfections were performed into HEK293T cells essentially as described [19] using 20 lg lentiviral plasmid, 2 lg pVSVG, 8 lg pPAX2 (Addgene, Cambridge, Massachusetts, USA), and 60 ll Lipofectamine 2000 (Invitrogen). Viral supernatants were collected 48 h after transfections, filtered through 0.45 lm pore size filter (Millipore) and supplemented with 8 lg/ml Polybrene (Sigma-Aldrich) prior to infecting MCF-7 cells. Puromycin (1 lg/ml; Sigma-Aldrich) was added to the culture medium 96 h after infection.
Antibodies and reagents
Antibodies used were C20 for sorcin (Santa Cruz Biotechnology), 14C10 for GAPDH, 24E10 for E-cadherin, and D80D3 for ZEB1 (Cell Signaling Technology). Adriamycin was purchased form Pharmacia & Upjohn SpA (Milan, Italy). Etoposide and methylthiazolyldiphenyl-tetrazolium bromide (MTT) were purchased from Sigma (St. Louis, MO).
RNA isolation and real-time reverse transcription-PCR Total RNA was isolated using Trizol (Invitrogen) following the manufacturer's protocols. The cDNA was generated using OligdT primers and SuperScriptIII reverse transcriptase (Invitrogen) using 1 lg total RNA. Real-time PCR was performed using an ABI SDS7000 (Applied Biosystems, Foster City, CA), in combination with SYBR Green I (Takara). Specific primers for each gene (Supplementary Table  S1 ) were selected using Primer Express (Applied Biosystems). The efficiencies of amplification of each primer pair were in the range of 95.3-99.2 %. PCR amplifications included a standard curve for each amplified gene in order to extrapolate transcript amounts from the Ct values. Relative transcript expression was normalized to that of GAPDH mRNA [20] .
Protein extraction and western blotting
A modified RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 0.25 % SDS, 1 % Triton X-100, 0.25 % sodiumdeoxycholate, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol) with protease inhibitor cocktail (Sigma) was used for protein isolation. Protein concentrations were determined using the BCA Protein Assay Kit (Pierce, Rockford, IL, USA). Cell lysates containing 50 lg of total protein were resolved on 12 % polyacrylamide gels and transferred to nitrocellulose membranes (Millipore, Billerica, MA, USA),and blocked with 5 % blotting grade milk (Bio-Rad, Hercules, CA, USA) in PBST (0.1 % Tween 20 in PBS). Then membranes were incubated with primary antibodies at 4°C overnight (dilution 1:100 for sorcin detection, dilution 1:1,000 for GAPDH, E-cadherin and ZEB-1 detection), followed by HRP-conjugated secondary antibodies (Cell Signaling Technology) at 1:2,000 dilution for 2 h at room temperature. Signals were visualized using SuperSignal West Pico Chemiluminescent Substrate (PIERCE, Rockford, IL, USA) according to the manufacturer's instructions.
IC 50
A MTT assay [21] was used to determine the drug concentrations producing 50 % cell growth inhibition (IC 50 ). Cells were seeded and cultured overnight in 96-well plates at a density of 5,000 cells/well, followed by incubation with drugs in triplicate.
In vitro growth curves
To determine growth rates, 1 9 10 4 cells were plated in each well of a 12-well plate (Corning). From the next day, cells were trypsinized and counted with a hematocytometer every day until day 7.
Wound healing assay
Cells were grown to confluence in a 6-well plate (Corning). After standard wounds were inflicted with a needle tip, images of wounded monolayers were obtained at 0 and 24 h.
Motility and invasion assays
For transwell assays, 1 9 10 5 cells were plated in the top chamber with the non-coated (motility assay) or Matrigelcoated (invasion assay) transwell inserts containing 8 lm filters (BD Falcon). In both assays, cells were plated in DMEM medium without serum, and DMEM medium supplemented with 20 % serum was used as a chemo attractant in the lower chamber. The cells were incubated for 24 h, and cells that did not migrate or invade through the pores were removed by a cotton swab. Cells on the lower surface of the membrane were stained with the DiffQuick Staining Set (Dade Behring) and counted.
Enzyme-linked immunosorbent assay (ELISA) Cells (3 9 10 5 ) were plated in a 6-well plate with DMEM medium supplemented with 10 % serum and incubated for 24 h. Medium was replaced with 2 ml serum-free DMEM for another 24 h and then collected for ELISA. Blood was taken from tumor-bearing mice and immediately placed into EDTA-treated tubes (BD Biosciences). Plasma was obtained by removing blood cells through centrifugation at 1,8009g for 15 min. VEGF levels in both the cell culture medium and plasma of mice were measured by a commercial VEGF ELISA kit (R&D Systems) according to the manufacturer's instructions.
Flow cytometry
For cell apoptosis analysis, cells were labeled using an annexin V-FITC and propidium iodide double-staining apoptosis detection kit (Becton Dickinson, Mountain View, CA) according to the manufacturer's instructions. Stem cell markers, FITC-conjugated CD44 and PE-conjugate CD24 (BD Biosciences) were used as described [21] . An Aldefluor assay kit (StemCell Technologies) was used for the determination of aldehyde dehydrogenase (ALDH) activity by flow cytometry as described [22] .
Soft agar colony formation assay Cells were disassociated, suspended in DMEM containing 0.3 % agar, and plated onto a bottom layer containing 0.6 % agar. The cells were plated at a density of 2 9 10 5 cells/well of 6-well plate, and the colonies were counted and stained with 0.1 % crystal violet 21 days later.
Mammosphere culture Cells (1 9 10 3 ) were plated in each well of an ultralow attachment plate (Corning) with 3 ml serum-free mammary epithelial growth medium (MEGM, BioWhittaker), supplemented with B27 (Invitrogen), 20 ng/ml EGF and 20 ng/ml bFGF (BD Biosciences). Colony formation was assessed 10 days later.
In vivo pulmonary metastatic assay All animal studies were performed at the Chinese Academy of Medical Sciences and Peking Union Medical College in accordance with guidelines under IACUC and approved by the State Key Laboratory of Experimental Hematology Ethical Committee. Nude mice (5-6 weeks of age; PUMC) were used in the study and received 400 rad of c-radiation using a dual 137Cs source 1 day before tumor cell injection. Tumor cells (5 9 10 6 ) in 100 ll PBS were injected into the mammary fat pad. Tumor sizes were measured every four days in two dimensions using a caliper, and the tumor volume was calculated with the following formula: tumor volume (mm 3 ) = 0.5 9 ab 2 (a and b being the longest and shortest diameters of the tumor, respectively). Approximately 30 days after transplantation, the mammary tumors were removed and weighed. The tumors, lungs, livers, and spleens were fixed in 10 % buffered formalin and then embedded in paraffin, sectioned, and stained with hematoxylin and eosin. The lung metastatic nodules were checked under the microscope.
Statistical analysis
A t test was used when comparing samples. Statistical significance was considered when P \ 0.05.
Results
Experimental down-regulation of sorcin increases drug sensitivity
We initially found that invasive MDA-MB-231 cells expressed higher levels of sorcin than non-invasive MCF-7 cells (Fig. 1a) . To investigate the role of sorcin in malignant tumor metastasis, we generated MDA-MB-231 cells in which sorcin was knocked-down by stable expression of a short hairpin. Two randomly selected clones, MDA-E3 and MDA-D4 (with sorcin down-regulation of *50 % at the RNA level and 70 % at protein level), were isolated (Fig. 1b) . A randomly selected clone, MDA-NC, was picked up from the pool of the transfection with the scrambled sequence and was used as control. The change in sorcin expression was not associated with cell proliferation as both types of cell showed identical growth rates (Fig. 1c) . As sorcin is closely associated with multidrugresistance, we asked whether down-regulation of sorcin could sensitize MDA-MB-231 cells to chemotherapeutic agents. As expected, the adriamycin IC 50 values decreased by 60-70 % (63.7 % in MDA-E3 cells and 71.1 % in MDA-D4 cells when compared to MDA-NC control cells). Equally, sorcin-depleted cells were more sensitive to etoposide (IC 50 reduction of *88 % ; Fig 1d; Supplementary  Fig. S1 ). This change in drug sensitivity following sorcin down-regulation was further confirmed by analyzing apoptosis after etoposide treatment (Fig. 1e) . Thus, the experimental down-regulation of sorcin leads to an increase in drug sensitivity.
Sorcin silencing inhibits EMT in MDA-MB-231 cells As sorcin knockdown led to a change in the morphology of MDA-MB-231 cells (from mesenchymal-like to epitheliallike, Fig. 2a) , we asked whether other traits of mesenchymal cells could be regulated by sorcin expression. For this, we initially tested the motility of cells using wound healing assays and found that sorcin-depleted cells were less motile than the corresponding control cells (Fig. 2b) . This was further confirmed quantitatively using transwell assays (with or without Matrigel) in transient tranfections (Supplementary Fig. S2a ) and isolated clones (Fig. 2a-d) . These changes in cell morphology, motility, and invasion suggest that sorcin silencing compromises EMT progression in MDA-MB-231 cells.
To further investigate how aberrant expression of sorcin leads to phenotypic changes in MDA-MB-231 cells, we monitored some EMT markers. Expression of the most significant epithelial marker, E-cadherin, increased remarkably in MDA-E3 cells, and MDA-D4 cells (Fig. 2e, g ). Moreover, down-regulation of expression of ZEB-1, a key transcriptional repressor of E-cadherin, accompanied sorcin downregulation (Fig. 2f, g ), indicating another potential regulator linked between sorcin and E-cadherin.
Angiogenesis is an important process for the generation of metastases [2] and VEGF is a potent mediator of angiogenesis. We found that VEGF-A was markedly reduced at both mRNA and protein levels in sorcin-depleted cells (Fig. 2h) . Thus, sorcin silencing leads to the inhibition of EMT in breast cancer cells.
Suppression of sorcin reduces the stem cell sub-population of MDA-MB-231 cells As sorcin knockdown led to an inhibition of EMT and EMT can generate cells with characteristics of stem cells [1] , we asked whether these changes affected also the stemness of MDA-MB-231 cells. We analyzed, first, the expression CD44 and CD24, two cell-surface markers whose expression in the CD44 high /CD24 low configuration is associated with human breast CSCs [21] . The percentage of CD44 high /CD24 low cells was reduced in sorcin knockdown cells (Fig. 3a) . We then analyzed ALDH activity, another important marker of CSCs [23] and found that it was remarkably diminished in sorcin-depleted cells ( Fig. 3b;  Supplementary Fig. S2b ).
To further assess whether silencing of sorcin influences the stemness and tumorigenicity of tumor cells, we tested both anchorage independence in soft agar, as only stem cell-like cells are able to survive and form clones in nonadherent conditions, as well as mammosphere formation [24] . We observed that sorcin-depleted cells produced less than half the number of mammospheres ( Fig. 3c;   Supplementary Fig. S2c ) and clones in soft agar (Fig. 3d) , when compared to control cells.
Thus, experimental down-regulation of sorcin in MDA-MB-231 cells reduces their CSC characteristics and tumor formation.
Silencing of sorcin inhibits MDA-MB-231 cells metastasis in vivo
As silencing of sorcin inhibited EMT and reduced the stemness of MDA-MB-231 cells in vitro, we asked whether the effects of sorcin depletion on tumor growth and Supplementary Fig. S1 ). e Apoptosis analysis by annexin V staining. Cells were treated with 10 lg/ml etoposide for 48 h and then stained with annexin V-FITC and propidium iodide. Apoptotic cells (annexin V-positive, propidium iodidenegative) were determined by flow cytometry. Numerical data represent mean ± SEM based on three independent experiments. *P \ 0.05; **P \ 0.01; ***P \ 0.001. Pictorial data show a representative of three independent replicates . Numerical data represent mean ± SEM based on three independent experiments. **P \ 0.01; ***P \ 0.001 Fig. 4a, b) . 33 days after injection, the tumor and organs were removed for further analysis. Visible lung metastases could be found in all four mice injected with control cells, whereas no metastasis was found in either the MDA-E3 or MDA-D4 group (Fig. 4c) . We confirmed that tumors generated from sorcin-depleted cells had a lower expression of sorcin, but higher expression of E-cadherin than the tumors generated from control cells (Fig. 4d) . In addition, the former also showed lower VEGF mRNA levels than the latter. This was further confirmed when the VEGF levels in plasma were determined (Fig. 4e) .
Thus, sorcin silencing in MDA-MB-231 cells inhibits tumor growth and metastasis spread in vivo.
Effects of sorcin depletion/overexpression on other tumor cells
To further verify the relationship of sorcin with migration and invasion, we used breast cancer MCF-7, lung adenocarcinoma A549, and lung fibrosarcoma HT1080 cells. For this, we stably over-expressed sorcin in MCF-7 and transiently knocked-down sorcin by RNA interference in A549 and HT1080 cells. Sorcin mRNA levels increased over fivefold in MCF-7 and decreased by *60 % in A549 and HT1080 cells (Fig. 5a ). We then analyzed the motility and invasive properties of these cells in transwells without or with Matrigel, respectively. Down-regulation of sorcin led to a decrease in both the motility and invasion of HT1080 and A549 cells when compared to those transfected with scrambled siRNA (Fig. 5b) , whereas overexpression of sorcin improved the migratory and invasive abilities of MCF-7 cells (Fig. 5c ). This confirms that the results shown in previous sections are not exclusive to MDA-MB-231 cells, and thus sorcin depletion reverse the invasive phenotype of cancer cells.
Discussion
The findings presented here describe an unexpected convergence of three phenomena of fundamental importance in cancer biology via the calcium-binding protein sorcin. On one side, EMT is a key developmental program often activated during cancer invasion and metastasis [16] . On the other, sorcin has been documented as a chemoresistant protein in a variety of cancers [25] . In addition, a small set of tumor-initiating cells (often referred as CSCs) has been suggested to be not only responsible for resistance to chemotherapy, but also for cancer metastasis and tumor recurrence, always accompanied with EMT activation [26] [27] [28] . EMT generates cellular traits associated with highgrade malignancy leading to metastatic dissemination; in addition, CSCs induced from EMT are also able to generate drug resistance and poor outcome of cancer patients [5, 29] . The close relationship of these processes is evident as chemo-insensitive CSCs selected after chemotherapy treatment can execute the initial steps of the invasionmetastasis cascade that lead in turn to seed the large colonies of cancer cells that form macroscopic metastases [30] . Consequently, understanding of mechanisms underlying the development and association of EMT with chemoresistance is of the outmost significance for improving current therapeutic strategies.
Sorcin, a calcium-binding protein that modulates excitation-contraction coupling in the heart, contributes to calcium homeostasis in the heart sarcoplasmic reticulum and is often associated with drug resistance [31] . We have confirmed that its down-regulation increases adriamycin and etoposide sensitivity in MDA-MB-231 cells. Although the mechanism of drug resistance by sorcin has been poorly studied, it has recently been suggested that it enhances the accumulation of Ca2
? in the endoplasmic reticulum (ER) of colorectal cancer cells, thus preventing ER stress [32] . In leukemia cells, overexpression of sorcin leads to apoptosis evasion by increasing Bcl-2 and attenuating Bax expression [33] . Sorcin is involved in the regulation of Ca2 ? homeostasis in cardiomyocytes [32] , but the regulation of Ca2
? -mediated signaling pathways by sorcin in cancer is poorly studied. Besides triggering an accumulation of Ca2
? in the ER of colorectal cancer cells, sorcin leads to reduced cytosolic Ca2
? levels in K562 cells [34] . As increased cytosolic Ca2
? levels can lead to apoptosis and decreased content of Ca2
? in the ER is associated with resistance to apoptosis [11] , it is tempting to speculate that in breast cancer cells, sorcin silencing may lead to apoptosis by modulating intracellular Ca2
? levels. Consistent with a positive correlation between sorcin and lymph node metastasis in gastric cancer [35] , our results provide evidence that the experimental down-regulation of sorcin in cell systems reverts EMT by elevating E-cadherin expression, a hallmark of epithelial cells, leading to a inhibition of invasion. ZEB-1, a transcriptional factor which negatively regulates E-cadherin expression [36] was also down-regulated in sorcin-depleted cells. Others have reported markers associated also with both chemoresistance and EMT. For instance, the E-cadherin repressor SNAI1 not only enhances the effect of EMT, but also increases chemoresistance in colorectal cancer [37] , and in epithelial ovarian cancer, the blockade of endothelin A receptor-driven EMT overcomes chemoresistance and inhibits tumor progression, improving patient outcome [38, 39] . In breast cancer cells undergoing EMT, a remodeling of Ca2
? influx pathways, including elevated store-operated Ca2
? entry have been demonstrated [40] . Moreover, a variety of calcium-binding proteins contributes to carcinoma metastasis, including the S100 protein family and SPARC [41] [42] [43] [44] . Indeed, S100 proteins are up-regulated in the primary tumors of many cancers and their overexpression is often associated with poor patient prognosis due to their ability to induce cell migration and metastasis [45] .
Our results also provide a link between sorcin and CSCs. Although sorcin depletion in MDA-MB-231 cells does not affect proliferation in vitro, it leads to a decrease in the CD44
? /CD24 -and ALDH1 high populations and consequent formation of mammospheres and colonies in soft agar. Others have also described a variety of mechanisms of CSC generation following chemoresistance in breast cancer [46] [47] [48] . Whether sorcin regulates EMT and CSCs directly or, more likely, indirectly remains to be determined.
How sorcin regulates VEGF is even more intriguing. Our data shows that down-regulation of sorcin leads to a decrease in VEGF expression both in cell systems and in the tumors of nude mice. Angiogenesis is a hallmark of cancer [22, 49] , and VEGF mediates a wide range of changes within the tumor vasculature, including cell proliferation, migration, invasion, and survival in many solid cancers [50, 51] . Importantly, VEGF and intracellular Ca2
? levels are frequently associated [52] , although the molecular mechanisms remain obscure. It may also be plausible that VEGF signaling represents a ''salvage pathway'' occurring during the development of chemoresistance.
Discovery of novel molecular targets to reduce the CSC population and inhibit cancer metastasis is of paramount significance. As sorcin depletion reduces breast cancer cells growth and metastasis, impedes angiogenesis in vivo, reduces the CSC population, and sensitizes cancer cells to chemotherapeutics, this offers the rationale for the development of anti-sorcin therapies in breast cancer.
